| Doctor-perceived-barriers to telephone clinics at KwaZulu-Natal hospitals during the COVID-19 pandemic L Pillay, R Govender, S Pillay South African Family Practice 63 (3), 2021 | 7 | 2021 |
| The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study LA Hall, SC McKay, J Halle-Smith, J Soane, DC Osei-Bordom, ... British Journal of Cancer, 2023 | 6 | 2023 |
| Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn’s Disease: A Review of Comparative Effectiveness Studies MT Sharip, N Nishad, L Pillay, N Goordyal, S Goerge, S Subramanian Journal of Clinical Medicine 13 (8), 2187, 2024 | 4 | 2024 |
| Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK OD Tavabie, KWM Abeysekera, PN Brennan, T Marjot, VT Kronsten, W Li, ... The Lancet Gastroenterology & Hepatology 8 (7), 604-606, 2023 | 4 | 2023 |
| Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study M Iacucci, S Bonovas, A Bazarova, R Cannatelli, RJM Ingram, N Labarile, ... Gastrointestinal Endoscopy 99 (5), 756-766. e4, 2024 | 2 | 2024 |
| The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis L Pillay, S Subramanian Inflammatory Bowel Diseases, izae025, 2024 | 1 | 2024 |
| Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis OD Tavabie, J Abbott, KWM Abeysekera, VK Balachandrakumar, ... Journal of Hepatology 79 (4), e165-e167, 2023 | 1 | 2023 |
| P0589 High treatment persistence following infliximab dose escalation in Inflammatory Bowel Disease: A real world study O Salehi, F Gondal, M Terlato, L Pillay, F Macrae, C Rentsch, S Dimkovski, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1174-i1174, 2025 | | 2025 |
| P1215 Hospital utilisation for ulcerative colitis in Australia, 1993–2022: a review of observational separation data E Meehan, L Pillay Journal of Crohn's and Colitis 19 (Supplement_1), i2201-i2201, 2025 | | 2025 |
| P0914 Clinical outcomes of dose-escalated adalimumab in Inflammatory Bowel Disease: A retrospective tertiary centre experience M Terlato, O Salehi, F Gondal, L Pillay, F Macrae, C Rentsch, S Dimovski, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1719-i1720, 2025 | | 2025 |
| P0364 Establishment and validation of a central reader pool for magnetic resonance enterography (MRE) for use in Crohn’s disease clinical trials L Pillay, H Paverd, N Noor, K Hickman, K De Paepe, EM Godfrey, ... Journal of Crohn's and Colitis 19 (Supplement_1), i837-i838, 2025 | | 2025 |
| P2 A regional evaluation of outcomes at three months for patients admitted to hospital with decompensated alcohol related cirrhosis C Oldroyd, S Pan, J Patel, P Khanna, S Sinclair, S Sen, M Bhuva, H Khan, ... Gut 73 (Suppl 3), A12-A12, 2024 | | 2024 |
| P103 Multi-site analysis of upadacitinib effectiveness in Crohn’s disease patients: a UK perspective C Radia, Y Danso, K Yeung, MA Hussain, C Dong, T Morris, C Patel, ... Gut 73 (Suppl 1), A111-A112, 2024 | | 2024 |
| O2 Beyond the first attempt: a multi-centre UK analysis of second JAK inhibitor use in ulcerative colitis Y Danso, C Radia, L Pillay, A Walsh, A Elford, C Patel, M Hale, R Pollok, ... Gut 73 (Suppl 1), A1-A2, 2024 | | 2024 |
| P514 Beyond the First Attempt: A Multi-Centre UK Analysis of Second JAK Inhibitor Use in Ulcerative Colitis Y Danso, C Radia, A Kent, P Harrow, P Pavlidis, C Selinger, M Samaan, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1017-i1018, 2024 | | 2024 |
| Beyond the First Attempt: A Multi-Centre UK Analysis of Second JAK Inhibitor Use in Ulcerative Colitis Y Danso, C Radia, A Kent, P Harrow, P Pavlidis, C Selinger, M Samaan, ... JOURNAL OF CROHNS & COLITIS 18, I1010-I1011, 2024 | | 2024 |
| Multi-site analysis of upadacitinib effectiveness in Crohn's Disease patients: A UK perspective C Radia, Y Danso, K Kok, M Samaan, AJ Kent, P Pavlidis, K Patel, ... JOURNAL OF CROHNS & COLITIS 18, I1517-I1519, 2024 | | 2024 |
| P821 Multi-site analysis of upadacitinib effectiveness in Crohn's Disease patients: A UK perspective C Radia, Y Danso, K Kok, M Samaan, AJ Kent, P Pavlidis, K Patel, ... Journal of Crohn's and Colitis 18 (Supplement_1), i1527-i1529, 2024 | | 2024 |
| P226 Does Prucalopride improve outcomes in colon capsule endoscopy? L Pillay, O Esan, AG Petre, M Macedo, M McStay Gut 72 (Suppl 2), A170-A170, 2023 | | 2023 |
| Intestinal ultrasound predicts medication escalation in Crohn's disease and is not associated with clinical symptoms. L Pillay, S Sane, A Wang, E Shelton Journal of Gastroenterology and Hepatology, 2022 | | 2022 |
